Liu Ya, Gong Rongpeng, Ma Haixiu, Chen Siai, Sun Jingwei, Qi Jiarui, Pang Yidan, An Juan, Su Zhanhai
Department of Basic Medical Sciences, Qinghai University Medical College, Xining, China.
Key Laboratory for High Altitude Medicine, Research Center for High Altitude Medicine, Xining, China.
Front Nutr. 2022 Jun 7;9:878665. doi: 10.3389/fnut.2022.878665. eCollection 2022.
Previous clinical studies and randomized controlled trials have revealed that low serum vitamin D levels are associated with the risk of developing insulin resistance. Magnesium has been reported to be a protective factor for insulin resistance, and magnesium has been considered an important co-factor for vitamin D activation. However, the effect of dietary magnesium intake on the relationship between vitamin D and the risk of developing insulin resistance has not been comprehensively investigated. Therefore, we designed this cross-sectional analysis to assess whether dietary magnesium intake modifies the association of vitamin D and insulin resistance.
A total of 4,878 participants (male: 48.2%) from 4 consecutive cycles of the National Health and Nutrition Examination Survey (2007-2014) were included in this study after a rigorous screening process. Participants were stratified by their dietary magnesium intake into low-intake (<267 mg/day) and high-intake (≥267 mg/day) groups. We assessed differences between serum vitamin D levels and the risk of developing insulin resistance (interaction test), using a weighted multivariate logistic regression to analyze differences between participants with low and high magnesium intake levels.
There was a negative association between vitamin D and insulin resistance in the US adult population [OR: 0.93 (0.88-0.98)], < 0.001. Dietary magnesium intake strengthened the association ( for interaction < 0.001). In the low dietary magnesium intake group, vitamin D was negatively associated with the insulin resistance [OR: 0.94 (0.90-0.98)]; in the high dietary magnesium intake group, vitamin D was negatively associated with insulin resistance [OR: 0.92 (0.88-0.96)].
Among adults in the United States, we found an independent association between vitamin D level and insulin resistance, and this association was modified according to different levels of magnesium intake.
既往临床研究和随机对照试验表明,血清维生素D水平低与发生胰岛素抵抗的风险相关。镁被报道为胰岛素抵抗的保护因素,且镁被认为是维生素D激活的重要辅助因子。然而,膳食镁摄入量对维生素D与胰岛素抵抗发生风险之间关系的影响尚未得到全面研究。因此,我们设计了这项横断面分析,以评估膳食镁摄入量是否会改变维生素D与胰岛素抵抗之间的关联。
经过严格筛选过程,本研究纳入了来自美国国家健康与营养检查调查(2007 - 2014年)连续4个周期的4878名参与者(男性占48.2%)。参与者根据膳食镁摄入量分为低摄入量组(<267毫克/天)和高摄入量组(≥267毫克/天)。我们评估了血清维生素D水平与发生胰岛素抵抗风险之间的差异(交互作用检验),使用加权多变量逻辑回归分析低镁摄入量和高镁摄入量参与者之间的差异。
在美国成年人群中,维生素D与胰岛素抵抗之间存在负相关[比值比:0.93(0.88 - 0.98)],<0.001。膳食镁摄入量增强了这种关联(交互作用P<0.001)。在低膳食镁摄入量组中,维生素D与胰岛素抵抗呈负相关[比值比:0.94(0.90 - 0.98)];在高膳食镁摄入量组中,维生素D与胰岛素抵抗呈负相关[比值比:0.92(0.88 - 0.96)]。
在美国成年人中,我们发现维生素D水平与胰岛素抵抗之间存在独立关联,且这种关联会根据不同的镁摄入量水平而改变。